How to select the optimal therapy for early-stage prostate cancer Journal Article


Authors: Kollmeier, M. A.; Zelefsky, M. J.
Article Title: How to select the optimal therapy for early-stage prostate cancer
Abstract: Selecting the "optimal therapy" for the patient with localized prostate cancer may be one of the most challenging medical decisions facing the oncologist. Most patients will have a number of appropriate therapeutic options available to them. Before determining which therapy is most appropriate for a patient, a critical question which needs to be asked is whether any therapy is necessary, especially for those who present with early-stage, low-grade, low-volume disease. Furthermore, given the lack of randomized trials available to guide physicians regarding the superiority of one therapy over another, it is important to consider the different side-effect profiles relevant for each treatment modality. The potential toxicities of therapy impact quality-of-life outcomes and play an important role for most patients in their individual selection of a particular therapy. In addition, there are other important issues that need to be considered, which include the medical condition of the patient and emotional and psychological considerations, as well as family/peer viewpoints or perceived notions of a particular therapy. This review will discuss the relevant issues in the decision making and treatment selection for the patient. © 2011 Elsevier Ireland Ltd.
Keywords: treatment outcome; review; intensity modulated radiation therapy; patient selection; cancer radiotherapy; cancer staging; nuclear magnetic resonance imaging; neoplasm staging; diagnostic accuracy; medical decision making; prostate specific antigen; quality of life; tumor volume; cancer screening; cancer mortality; cancer hormone therapy; prostate cancer; prostatic neoplasms; prostate; urine incontinence; prostatectomy; high intensity focused ultrasound; prostate biopsy; brachytherapy; nuclear magnetic resonance spectroscopy; surgery; medical specialist; patient decision making; external beam radiotherapy; stereotactic body radiation therapy; erectile dysfunction; androgen deprivation therapy; patient counseling; patient referral; predictive value; cryotherapy; disease surveillance; proctitis; treatment selection; obstructive uropathy
Journal Title: Critical Reviews in Oncology/Hematology
Volume: 83
Issue: 2
ISSN: 1040-8428
Publisher: Elsevier Science, Inc.  
Date Published: 2012-08-01
Start Page: 225
End Page: 234
Language: English
DOI: 10.1016/j.critrevonc.2011.11.001
PROVIDER: scopus
PUBMED: 22154187
DOI/URL:
Notes: --- - "Export Date: 1 August 2012" - "CODEN: CCRHE" - "Source: Scopus"
Altmetric
Citation Impact
MSK Authors
  1. Michael J Zelefsky
    750 Zelefsky
  2. Marisa A Kollmeier
    213 Kollmeier